EPCAM and ovarian carcinoma: Ovarian cancer cell lines with high EpCAM expression have been shown to be resistant to T-cell-mediated killing; however, following incubation with solitomab (1 μg/mL), they became highly sensitive to T-cell-mediated killing [99].